Insomnia
300 results
200 - 299Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment
'Third wave' cognitive and behavioural therapies versus other psychological therapies for depression: Cochrane systematic review
Tapentadol for chronic musculoskeletal pain in adults
Bright light therapy for sleep problems in adults aged 60+
Acute psychosis
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Controlled-release combo of phentermine and topiramate decreases weight (CONQUER)
Duloxetine reduces pain from chemotherapy-induced peripheral neuropathy
Mefloquine for preventing malaria during travel to endemic areas
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia
Opioid antagonists with minimal sedation for opioid withdrawal
Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome
Behavioural therapies versus other psychological therapies for depression
Green tea (Camellia sinensis) for the prevention of cancer
'Third wave' cognitive and behavioural therapies versus treatment as usual for depression: Cochrane systematic review
Nasal decongestants for the common cold: Cochrane systematic review
Ganoderma lucidum (Reishi mushroom) for cancer treatment
Cognitive behavioural interventions for sleep problems in adults aged 60+
Honey for acute cough in children
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
Effects of opioid, hypnotic and sedating medications on sleep‐disordered breathing in adults with obstructive sleep apnoea
Treating opioid use disorder in primary care—limited data, but looks feasible
Cholinesterase inhibitors for mild cognitive impairment
Interventions for treating acute high altitude illness: Cochrane systematic review
Home-based multidimensional survivorship programmes for breast cancer survivors: Cochrane systematic review
Adrenergic drugs for urinary incontinence in adults: Cochrane systematic review
Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
Autism spectrum disorder
Smoking cessation
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
Adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications
Peer support for people with schizophrenia or other serious mental illness
S‐adenosyl methionine (SAMe) for depression in adults
Second‐generation antidepressants for preventing seasonal affective disorder in adults
Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
Selective serotonin re‐uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)
Antivirals for idiopathic sudden sensorineural hearing loss: Cochrane systematic review
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non‐randomised studies
Depression in adolescents
Memory complaints, mild cognitive impairment and dementia
Pharmacological treatment of depression
Interventions for chronic pruritus of unknown origin
Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea
Telerehabilitation for persons with multiple sclerosis
Aripiprazole versus placebo for schizophrenia: Cochrane systematic review
Oral budesonide for induction of remission in ulcerative colitis
Mental disorders due to somatic disease
Drug therapy for preventing post‐dural puncture headache
Therapeutic drug monitoring of antiretrovirals for people with HIV
Laquinimod for multiple sclerosis: Cochrane systematic review
Acupuncture
Oral budesonide for induction of remission in ulcerative colitis
Risperidone versus olanzapine for schizophrenia
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease: Cochrane systematic review
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders
Budesonide for maintenance of remission in Crohn's disease
Seasonal affective disorder (SAD)
Oestrogen and combined oestrogen/progestogen replacement therapy for hot flushes
Short‐course oral steroids as an adjunct therapy for chronic rhinosinusitis
Ginkgo biloba for tinnitus
Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome
Psychosocial interventions for benzodiazepine harmful use, abuse or dependence
Pharmacotherapy for sleep bruxism
Acupuncture for schizophrenia
Honey for acute cough in children
Fluvoxamine for the treatment of COVID‐19
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications: Cochrane systematic review
Antidepressants for people with epilepsy and depression
Systemic and topical antibiotics for chronic rhinosinusitis
Sound therapy (using amplification devices and/or sound generators) for tinnitus
Placebo interventions for all clinical conditions: Cochrane systematic review
Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults
Antidepressants for the treatment of depression in people with cancer
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease
Antidepressants plus benzodiazepines for adults with major depression
Pharmacotherapies for sleep disturbances in dementia
Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
Pharmacological intervention for irritability, aggression, and self‐injury in autism spectrum disorder (ASD)
Lifestyle education in type 2 diabetes
Neuromodulators for pain management in rheumatoid arthritis
Varenicline and bupropion and suicidal behaviour
Functional bowel disorders and the irritable bowel syndrome (IBS)